Form 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2010

Commission File No. 333-05752

 

 

CNH GLOBAL N.V.

(Translation of Registrant’s Name Into English)

 

 

World Trade Center

Tower B, 10th Floor

Amsterdam Airport

The Netherlands

(Address of Principal Executive Offices)

 

 

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F  x            Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1):  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7):  ¨

(Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)

Yes  ¨            No  x

(If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-             .)

 

 

 


CNH GLOBAL N.V.

Form 6-K for the month of April 2010

List of Exhibits:

 

1. News Release entitled, “CNH Reports Impact of Retiree Drug Benefits Change


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

CNH Global N.V.
By:  

/s/ Michael P. Going

  Michael P. Going
 

Senior Vice President, General Counsel and Secretary

April 7, 2010


LOGO

FOR IMMEDIATE RELEASE

For more information contact:

Gerry Spahn    Investor Relations    (630) 887-2385
Ralph Traviati    News and Information    (630) 887-2345

CNH Reports Impact of Retiree Drug Benefits Change

BURR RIDGE, ILL., - (April 6, 2010) - CNH Global N.V. (NYSE: CNH) today reported that, under the new Patient Protection and Affordable Care Act, to the extent CNH’s future health care drug expenses are reimbursed under the Medicare Part D retiree drug subsidy program, such expenses will no longer be tax deductible. CNH will reflect the full tax impact of this change, an after-tax charge of $20 million, in its results for the first quarter of 2010.

###

CNH Global N.V. is a world leader in the agricultural and construction equipment businesses. Supported by more than 11,600 dealers in approximately 170 countries, CNH brings together the knowledge and heritage of its Case and New Holland brand families with the strength and resources of its worldwide commercial, industrial, product support and finance organizations. CNH Global N.V., whose stock is listed at the New York Stock Exchange (NYSE:CNH), is a majority-owned subsidiary of Fiat S.p.A. (FIA.MI). More information about CNH and its Case and New Holland products can be found online at www.cnh.com.

 

Page 1